Augmenting Rehabilitation Outcomes and Functional Neuroplasticity Using Epidural Stimulation of Cervical Spinal Cord
The Methodist Hospital Research Institute · NCT06225245
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 22–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 12
- US sites recruiting
- 1
- Study start
- August 6, 2024
- Record last updated
- April 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to investigate the effects of cervical epidural spinal stimulation with upper extremity training.
This is an investigational study. The device used for epidural spinal stimulation (ESS) to deliver spinal stimulation is called the CoverEdgeX 32 Surgical Lead system. This device is approved by the Food and Drug Administration (FDA) for the treatment of severe pain and to manage chronic pain when other treatments have not been effective. In this study, the device is considered an investigational device because it is not approved for use in the treatment of spinal cord injury
Being studied: Epidural Spinal Stimulation (ESS)
Conditions: Spinal Cord Injuries; Cervical Spinal Cord Injury
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- All participants must provide a signed and dated informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Male or female aged 22 - 65 years old.
- Must provide documentation from personal primary treating physician that reports stable medical condition.
- Able to passively range bilateral upper extremities within normal mobility parameters including:
- greater than 90 degrees of shoulder flexion and 20 degrees of shoulder extension;
- greater than 120 degrees of elbow flexion and reach elbow extension of approximately 150 degrees;
- neutral wrist position reaching a minimum of 70 degrees of movement (between flexion and extension;
- ability to passively flex and extend fingers.
- Maintain current oral anti-spasticity regimen/dosage as approved by study physician with no change in regular use that may affect study outcomes.
- Six (6) months to 20 years post spinal cord injury.
- Non-progressive spinal cord injury.
- Chronic SCI with neurologic level of injury as defined by ISNCSCI AIS A, B, or C.
- Neurological level of injury above T2.
- Eligible for fMRI per safety questionnaire.
- Women of childbearing potential must agree to the use of an effective means of avoiding pregnancy for the duration of the study.
Exclusion Criteria
- Currently involved in another rehabilitation training study.
- Lower motor neuron injury revealed in the upper limbs.
- Stabilization hardware in the cervical spine, preventing implantation of ESS system.
- Active pressure sores, wounds, unhealed bone fractures, peripheral neuropathies, or painful musculoskeletal dysfunction (including contractures in the upper and lower extremities).
- Any ongoing medical condition which would preclude participant from regular physical activity (including but not limited to: ventilator dependence, cardiopulmonary disease, uncontrollable autonomic dysreflexia or orthostatic hypotension, active urinary tract infections, pregnant or nursing).
- Intrathecal baclofen pump therapy for spasticity.
- Must not have received Botox injections to primary lower extremity and trunk musculature within the past 3 months which would result in absence of muscle tone and thus preclude response to electrical stimulation therapy.
- Current or history of neuromuscular conditions (including but not limited to: unhealed ligament of muscular tears in the upper or lower extremities, pain in weight bearing positions for upper and lower extremities).
- Clinically significant depression, psychiatric disorders, or ongoing drug abuse.
- Any reason the PI or treating physician may deem as harmful to the participant or inappropriate for the participant to enroll or continue in the study.
- Body Mass Index (BMI) over 30.
- Pregnancy.
Recruiting US locations
The Methodist Hospital Research Institute
Houston, TX 77030
Site contact: Jenny Dinh · 346-238-4654 · jtdinh@houstonmethodist.org
Study contacts (from the official record)
- Jenny Dinh · 346-238-4654 · jtdinh@houstonmethodist.org
- Rachel Markley · 713-441-3770 · rmarkley@houstonmethodist.org
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75